The beneficial effect of vagotomy in patients with duodenal ulceration is believed to depend on the halving of the gastric secretion of acid which follows the operation, and which persists for at least three years (Bell, 1964). It would be advantageous if a similar reduction in secretion could be produced by blocking the action of the vagus nerves pharmacologically-for example, with an anticholinergic compound-without the occasional ill effects of surgical vagotomy. However, the orthodox view is that " the anticholinergic drugs do not reduce the acidity of the gastric contents in patients taking food, and their only real value is as antispasmodics" (B.M.7., 1963). The heterodox view is that atropine, and poldine methylsulphate (Nacton), as examples of drugs with tertiary and quaternary nitrogen, in doses which produce no side-effects, do inhibit gastric secretion of acid in response to food (Mitchell, Hunt, and Grossman, 1962 ).
The beneficial effect of vagotomy in patients with duodenal ulceration is believed to depend on the halving of the gastric secretion of acid which follows the operation, and which persists for at least three years (Bell, 1964) . It would be advantageous if a similar reduction in secretion could be produced by blocking the action of the vagus nerves pharmacologically-for example, with an anticholinergic compound-without the occasional ill effects of surgical vagotomy. However, the orthodox view is that " the anticholinergic drugs do not reduce the acidity of the gastric contents in patients taking food, and their only real value is as antispasmodics" (B.M.7., 1963) . The heterodox view is that atropine, and poldine methylsulphate (Nacton) , as examples of drugs with tertiary and quaternary nitrogen, in doses which produce no side-effects, do inhibit gastric secretion of acid in response to food (Mitchell, Hunt, and Grossman, 1962 ).
An average reduction of the gastric secretion of acid by onehalf in a group of outpatients with peptic ulceration treated with poldine was reported four years ago (Douthwaite, Hills, and Hunt, 1961) . Before Hunt (1954) gives the volumes of 160 mN (160 mEq/L.) hydrochloric 
Present Investigation
The present report concerns the continued progress in the 16 cases described four years ago (Douthwaite et d., 1961 Table I . The case numbers correspond to those in Table I of the previous report (Douthwaite et al., 1961 There is evidence that peptic ulceration is a self-limiting disorder, provided that the patients survive the complications (Fr-y, 1964) . A treatment which relieved the pain and prevented complications occurring during the years of activity of the disorder would be a logical development.
Chronic peptic ulceration is usually ascribed to diminished mucosal resistance and relatively increased gastric secretion of acid. In the control of gastric secretion acetylcholine released by vagal terminations has direct stimulant and potentiating actions in the cephalic and gastric phases of the gastric secretion of acid (Grossman, 1963) . Reduction of vagal activity can therefore be regarded as a specific treatment of one of the factors underlying peptic ulceration. Surgical vagotomy reduces the secretion of acid, but surgery entails time off work for the patients, and occasionally produces irreversible ill effects.
Reversible pharmacological blockade of cholinergic activity would seem to be preferable to vagotomy, but it must be achieved with a drug which gives the continuous reduction of the gastric secretion of acid without the other effects of anticholinergic compounds, such as dryness of the mouth, blurring of near vision, and retention of urine. This would offer the possibility of patients with peptic ulceration reaching the stage of remission more safely, and perhaps more quickly.
Effects of Secretion
At doses given four times daily which produced no sideeffects poldine (Acred, Atkins, Bainbridge, Brown, Quinton, and Turner, 1957) has been shown to reduce the gastric secretion of acid under basal conditions (Seidelin, 1961) , in response to food (Mitchell et al., 1962) , in response to distension test meals (Douthwaite and Hunt, 1958) , and in response to maximal doses of histamine (Seidelin, 1961) . Because the secretory responses to a variety of stimuli are correlated on an ordinal scale (Hunt, 1950) , we have used the changes in response to a distension test meal as an index to the variations of the secretory responses to all stimuli.
In this study the reduced secretion of acid, as measured on active tablets, remained steady for up to seven years without any change in dose. On stopping active treatment after four years, unexpectedly the secretion of acid did not return to the initial untreated value. However, there was no evidence of this reduction when the patients were on inactive tablets after only six months of active treatment. At present we do not regard this long-term reduction of secretion, as measured when the patients were on inactive tablets, as being a direct effect of poldine, but as a manifestation of the course of the disorder, which is consistent with the view of Littman (1962) . This reduced secretion on inactive tablets was maintained in group II for at least two and a half years. We regard this value as the "norm" for our patients when they are well and not receiving drug treatment. In comparison with this norm, secretion of acid in hospital before treatment was raised. Also, on inactive tablets it was raised in outpatients after only six months of treatment with poldine. This may indicate that there was a predisposition to active ulceration at these times.
The effect of poldine on the combined acid and alkaline secretions resulted in a reduction by one-quarter in the concentration of acid in the mixed gastric juice. This reduction was consistent with the results of Kay and Smith (1956) (Siegel, 1956) with rest in bed, having long spells off work. Because of an increase in size of his ulcer he was admitted to hospital. On treatment with poldine in hospital he rapidly became free of pain, and the ulcer had healed by August 1957. His secretion of acid on inactive tablets, after the first six months on active tablets, was 55 ml. On active tablets the secretion of acid remained at about 20 ml. until he developed flatulence and vomiting in November 1963, when it suddenly increased to 43 and 47 ml., and recurrence of his ulcer was seen radiologically. After the treatment in hospital his ulcer healed and has remained so on active tablets. We conclude that the reduction in gastric secretion of acid from 55 ml. to 20 ml. may have prevented the recurrence of gastric ulcer. When his secretion rose he had a recurrence of his ulcer. It is interesting that the norm for this patient was 35 ml. of acid. Thus, although he did not have absolute hypersecretion at any time, when he had a relapse he secreted one-third more acid than he did when healthy. We do not know whether he was exposed to special stress, but there are several instances of hard physical work, worry, or unpleasant experience being associated with rises in gastric secretion of acid in patients receiving poldine, and in healthy subjects (Douthwaite et al., 1961 Hunt, 1950 There was a correlation between recorded pain and pretreatment secretion of acid.
Since poldine is as effective as vagotomy in reducing the secretion of acid by the stomach but has no significant undesirable actions, we suggest that it can be used in the treatment of duodenal ulceration in place of vagotomy provided there is no significant obstruction to gastric emptying. In our two patients with gastric ulcer poldine was effective in reducing gastric secretion of acid, and they fared well clinically.
Summary
Gastric secretion of hydrochloric acid, bicarbonate,and pepsin has been studied in patients with peptic ulceration treated with poldine methylsulphate for periods greater than five years, part of the time under double-blind conditions.
During this long period of treatment with active tablets the gastric secretion of acid, as measured on inactive tablets, had fallen, and had not risen again within 30 months (in patients continuing on inactive tablets). The secretion of acid on inactive tablets after prolonged treatment is thought to be the norm for the patients. The raised secretion of acid before treatment began and after only six months of active treatment is thought to indicate a predisposition to active ulceration at these times.
The halving of the gastric secretion of acid, relative to the pretreatment value, has been maintained for up to seven years by unchanged doses of poldine which did not cause undesirable effects.
Poldine reduced the concentration of acid in the gastric secretion in response to test meals from 100 to 75 mN. The output of pepsin was reduced more than the output of acid.
There was very little dyspepsia among these patients while they were on active tablets. Under double-blind conditions most patients did not relapse on inactive tablets. This might be attributed to the reduction in gastric secretion during longterm treatment with poldine.
Patients with high secretions of acid while on inactive tablets during their original illness recorded more pain throughout the whole trial than those with low secretions.
Though gastric emptying was slowed by about one-tenth by poldine, the long-term increase in the rate of gastric emptying during the period of treatment more than offset this slowing.
Undesirable toxic actions on the bone-marrow, liver, or kidneys were not detected.
No significant effect on intraocular pressure was found, even in a patient with a shallow anterior chamber.
Since poldine reduces gastric secretion by one-half, as does surgical vagotomy, but has no significant undesirable actions, it may be considered for the treatment of duodenal ulceration in place of vagotomy where there is no significant obstruction to gastric emptying.
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